CLEC4M Is Associated With Poor Prognosis and Promotes Cisplatin Resistance in NSCLC Patients
Journal of Cancer - Australia
doi 10.7150/jca.30139
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2019
Authors
Publisher
Ivyspring International Publisher